Details for Patent: 10,576,154
✉ Email this page to a colleague
Which drugs does patent 10,576,154 protect, and when does it expire?
Patent 10,576,154 protects MIEBO and is included in one NDA.
This patent has seventy-two patent family members in sixteen countries.
Summary for Patent: 10,576,154
| Title: | Semifluorinated alkane compositions |
| Abstract: | The invention provides novel compositions comprising semifluorinated alkanes and at least one compound sensitive or prone to oxidation. The compositions can be used as medicines that are topically administered to an eye or ophthalmic tissue. The invention further provides kits comprising such compositions. |
| Inventor(s): | Günther Bernhard, Scherer Dieter, Pettigrew Anthony, Theisinger Bastian, Theisinger Sonja |
| Assignee: | NOVALIQ GMBH |
| Application Number: | US16041317 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,576,154
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED) | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,576,154
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013314303 | ⤷ Sign Up | |||
| Australia | 2013314370 | ⤷ Sign Up | |||
| Australia | 2016219611 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
